会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Biological fluid delivery system
    • 生物流体输送系统
    • US5899873A
    • 1999-05-04
    • US823529
    • 1997-03-24
    • Kenneth A. JonesMartyn AbbottAndrew P. Mattson
    • Kenneth A. JonesMartyn AbbottAndrew P. Mattson
    • A61M1/36A61M37/00
    • A61M1/3664
    • A cardioplegia system for delivering cardioplegic solution to the heart during open heart surgery in cooperation with an extracorporeal blood circuit employing a heart/lung machine, includes a conduit diverting a portion of the blood flow from the heart/lung machine to a cardioplegia delivery line. A heat exchanger assembly including a heat exchanger for controlling fluid temperature is provided in the cardioplegia delivery line. In addition to a heat exchanger, the heat exchanger assembly includes an integral bubble trap, filtration means and means to enable the measurement of certain physical characteristics of the circulating cardioplegia fluid and/or certain events occurring within the heat exchanger assembly.
    • 一种心脏停搏系统,用于在开心心脏手术期间与使用心脏/肺机的体外血液回路相结合,将心脏停搏液提供给心脏,包括导管将一部分血流从心脏/肺机转移到心麻痹输送管线。 在心麻痹输送管线中设置有包括用于控制流体温度的热交换器的热交换器组件。 除了热交换器之外,热交换器组件还包括一体式气泡阱,过滤装置和能够测量循环心麻痹液体的某些物理特性和/或在热交换器组件内发生的某些事件的装置。
    • 6. 发明授权
    • Two-chamber blood pump
    • 双室血泵
    • US09234514B2
    • 2016-01-12
    • US12199593
    • 2008-08-27
    • Kenneth A. Jones
    • Kenneth A. Jones
    • F04B1/02A61M1/00F04B9/04F04B43/02A61M1/10F04B7/00F04B23/06F04B53/14
    • F04B43/02A61M1/1006A61M1/1037A61M1/1046A61M1/1081A61M1/1086A61M2202/047A61M2205/12F04B7/00F04B23/06F04B43/026F04B53/14
    • A fluid pump for medical applications. The pump includes a flexible cassette containing two pump chambers of differing volume, each chamber having a dedicated piston. The first piston pushes fluid from the first chamber to the second, and the second piston pushes fluid from the second chamber and out of the pump. Three valves are coordinated with the action of the pistons to control fluid flow into and out of the pump chambers by applying and releasing pressure to and from specific points of the flexible cassette. A control system controls the operation of the pistons and valves and directs the pistons to be advanced according to a time-varying velocity profile. The first pump chamber passively fills and then rapidly expels the collected fluid into the second chamber at low pressure. The second chamber, once filled, expels the fluid downstream at high pressure, producing a pulsatile pressure profile.
    • 用于医疗应用的流体泵。 该泵包括一个含有两个不同体积的泵室的柔性盒,每个室具有专用的活塞。 第一活塞将流体从第一腔室推动到第二活塞,第二活塞将流体从第二腔室推出泵出。 三个阀门与活塞的作用协调起来,以通过向和从该软管盒的特定点施加和释放压力来控制流入和流出泵室的流体。 控制系统控制活塞和阀的操作,并根据时变速度分布指示要提前的活塞。 第一泵室被动填充,然后在低压下将收集的流体快速排出到第二室中。 一旦装满了第二个室,高压下排出流体,产生脉动压力分布。
    • 7. 发明授权
    • Methods for preparing compositions using a SNORF33 receptor
    • 使用SNORF33受体制备组合物的方法
    • US07517658B2
    • 2009-04-14
    • US11227855
    • 2005-09-15
    • Beth E. BorowskyKristine L. OgozalekKenneth A. Jones
    • Beth E. BorowskyKristine L. OgozalekKenneth A. Jones
    • G01N33/567G01N33/53C07K14/47
    • C07K14/705A61K38/00A61K48/00
    • This invention provides isolated nucleic acids encoding mammalian SNORF33 receptors, purified mammalian SNORF33 receptors, vectors comprising nucleic acid encoding mammalian SNORF33 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF33 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian SNORF33 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF33 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian SNORF33 receptors, methods of isolating mammalian SNORF33 receptors, methods of treating an abnormality that is linked to the activity of the mammalian SNORF33 receptors, as well as methods of determining binding of compounds to mammalian SNORF33 receptors, methods of identifying agonists and antagonists of SNORF33 receptors, and agonists and antagonists so identified.
    • 本发明提供编码哺乳动物SNORF33受体的分离的核酸,纯化的哺乳动物SNORF33受体,包含编码哺乳动物SNORF33受体的核酸的载体,包含此类载体的细胞,针对哺乳动物SNORF33受体的抗体,用于检测编码哺乳动物SNORF33受体的核酸的核酸探针, 与编码哺乳动物SNORF33受体的核酸的独特序列互补的反义寡核苷酸,表达编码正常或突变的哺乳动物SNORF33受体的DNA的转基因非人动物,分离哺乳动物SNORF33受体的方法,治疗与哺乳动物的活性相关的异常的方法 SNORF33受体以及确定化合物与哺乳动物SNORF33受体的结合的方法,识别SNORF33受体的激动剂和拮抗剂的方法,以及所鉴定的激动剂和拮抗剂。
    • 8. 发明授权
    • DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
    • 编码哺乳动物神经肽FF(NPFF)受体的DNA及其用途
    • US06709831B1
    • 2004-03-23
    • US09405558
    • 1999-09-24
    • Christophe P. G. GeraldKenneth A. JonesJames A. BoniniBeth E. BorowskyDouglas A. Craig
    • Christophe P. G. GeraldKenneth A. JonesJames A. BoniniBeth E. BorowskyDouglas A. Craig
    • G01N33566
    • C07K14/70571A01K2217/075
    • This invention provides isolated nucleic acids encoding mammalian NPFF receptors, purified mammalian NPFF receptors, vectors comprising nucleic acid encoding mammalian NPFF receptors, cells comprising such vectors, antibodies directed to mammalian NPFF receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian NPFF receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian NPFF receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian NPFF receptors, methods of isolating mammalian NPFF receptors, methods of treating an abnormality that is linked to the activity of the mammalian NPFF receptors, as well as methods of determining binding of compounds to mammalian NPFF receptors, methods of identifying agonists and antagonists of NPFF receptors, and agonists and antagonists so identified.
    • 本发明提供编码哺乳动物NPFF受体的分离的核酸,纯化的哺乳动物NPFF受体,包含编码哺乳动物NPFF受体的核酸的载体,包含该载体的细胞,针对哺乳动物NPFF受体的抗体,用于检测编码哺乳动物NPFF受体的核酸的核酸探针, 与编码哺乳动物NPFF受体的核酸的独特序列互补的反义寡核苷酸,其表达编码正常或突变型哺乳动物NPFF受体的DNA的转基因非人动物,分离哺乳动物NPFF受体的方法,治疗与哺乳动物活性相关的异常的方法 NPFF受体,以及确定化合物与哺乳动物NPFF受体的结合的方法,识别NPFF受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。
    • 9. 发明授权
    • DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof
    • 编码哺乳动物神经肽FF(NPFF)受体的DNA及其用途
    • US06262246B1
    • 2001-07-17
    • US09255368
    • 1999-02-22
    • Christophe P. G. GeraldKenneth A. JonesJames A. BoniniBeth Borowsky
    • Christophe P. G. GeraldKenneth A. JonesJames A. BoniniBeth Borowsky
    • C07H2104
    • C07K14/70571A01K2217/075
    • This invention provides isolated nucleic acids encoding mammalian NPFF receptors, purified mammalian NPFF receptors, vectors comprising nucleic acid encoding mammalian NPFF receptors, cells comprising such vectors, antibodies directed to mammalian NPFF receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian NPFF receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian NPFF receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian NPFF receptors, methods of isolating mammalian NPFF receptors, methods of treating an abnormality that is linked to the activity of the mammalian NPFF receptors, as well as methods of determining binding of compounds to mammalian NPFF receptors, methods of identifying agonists and antagonists of NPFF receptors, and agonists and antagonists so identified.
    • 本发明提供编码哺乳动物NPFF受体的分离的核酸,纯化的哺乳动物NPFF受体,包含编码哺乳动物NPFF受体的核酸的载体,包含该载体的细胞,针对哺乳动物NPFF受体的抗体,用于检测编码哺乳动物NPFF受体的核酸的核酸探针, 与编码哺乳动物NPFF受体的核酸的独特序列互补的反义寡核苷酸,其表达编码正常或突变型哺乳动物NPFF受体的DNA的转基因非人动物,分离哺乳动物NPFF受体的方法,治疗与哺乳动物活性相关的异常的方法 NPFF受体,以及确定化合物与哺乳动物NPFF受体的结合的方法,识别NPFF受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。